The combined therapy of interferon-α plus ribavirin improved insulin resistance but unaffected the adiponectin levels in patients affiliated with chronic hepatitis C
碩士 === 弘光科技大學 === 生物科技研究所 === 96 === Insulin resistance may play an important role in the pathogenesis of type 2 diabetes in patients infected with chronic hepatitis C (HCV). A combination therapy of interferon-□ plus ribavirin has been the mainstay of treatment for chronic hepatitis C infection. Th...
Main Authors: | Shih-Ting Tseng, 曾士婷 |
---|---|
Other Authors: | Robert Y. Peng |
Format: | Others |
Language: | en_US |
Published: |
2008
|
Online Access: | http://ndltd.ncl.edu.tw/handle/02186310989081515001 |
Similar Items
-
Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
by: Gonçales Neiva SL, et al.
Published: (2010-07-01) -
Genetic variability of hepatitis C virus before and after combined therapy of interferon plus ribavirin.
by: José Manuel Cuevas, et al.
Published: (2008-08-01) -
Pegylated interferon-alfa plus ribavirin therapies for chronic hepatitis C
by: T Kanda, et al.
Published: (2011-03-01) -
Ribavirin plus interferon alfa in the treatment of chronic hepatitis C infection
by: Wen Hwang Chen, et al.
Published: (2000) -
Decrease in regulatory T-cell function in chronic hepatitis C patients receiving pegylated-interferon plus ribavirin
by: Kuo-Chih Tseng, et al.
Published: (2017-05-01)